Abner Herrman & Brock’s Idexx Laboratories IDXX Stock Holding History

Abner Herrman & Brock’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-1,000	Closed	-$261K	–	113
2019 Q4	$261K	Hold	1,000	–	–	0.04%	103
2019 Q3	$272K	Hold	1,000	–	–	0.04%	98
2019 Q2	$275K	Hold	1,000	–	–	0.04%	96
2019 Q1	$224K	Buy	+1,000	New	+$206K	0.03%	114
2018 Q4	–	Sell	-1,000	Closed	-$250K	–	127
2018 Q3	$250K	Hold	1,000	–	–	0.04%	112
2018 Q2	$218K	Buy	+1,000	New	+$206K	0.03%	119

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Abner Herrman & Brock's IDXX Position: Q1 2020 in Review

Abner Herrman & Brock sold out of Idexx Laboratories (IDXX) in Q1 2020, closing a stake of 1,000 shares — an estimated $261K sold.

Abner Herrman & Brock first reported a position in IDXX in Q2 2018 and held it in 6 quarters. The position peaked at $275K in Q2 2019. 748 funds tracked by Wall St. Rank hold IDXX as of Q1 2020.

Abner Herrman & Brock reported no remaining Idexx Laboratories position as of Q1 2020 after selling out during the quarter.
Abner Herrman & Brock sold 1,000 Idexx Laboratories shares in Q1 2020, an estimated $261K.
Abner Herrman & Brock first reported a position in Idexx Laboratories in Q2 2018 and held it in 6 quarters.
Abner Herrman & Brock's Idexx Laboratories position peaked at $275K in Q2 2019.
748 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2020.

Based on Abner Herrman & Brock's 13F filing for Q1 2020, filed 9 Apr 2020.